Researcher
Katrijn Grupping
Affiliations
- Virology (Research unit)
Member
From31 Jan 2012 → 30 Jul 2012
Publications
1 - 7 of 7
- M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding(2013)
Authors: P Selhorst, K. Grupping, T. Tong, E.T. Crooks, L. Martin, G Vanham, J.M. Binley, Kevin Ariën
Pages: 1-9 - Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011(2012)
Authors: N. Ruffin, M. Borggren, Z. Euler, F. Fiorino, K. Grupping, D. Hallengärd, A. Javed, K. Mendonca, C Pollard, D. Reinhart, et al.
Pages: 1-14 - In vitro activity of candidate microbicides against cell-associated HIV(2012)
Authors: P Selhorst, K. Grupping, T Bourlet, O Delezay, Kevin Ariën, G Vanham
Pages: 805-815 - MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency(2012)
Authors: K. Grupping, P Selhorst, J Michiels, K Vereecken, L Heyndrickx, P. Kessler, G Vanham, L. Martin, Kevin Ariën
Pages: 1-16 - Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference(2010)
Authors: B. Wahren, P. Biswas, M. Borggren, A Coleman, K Da Costa, W De Haes, T Dieltjens, S Dispinseri, K Grupping, D Hallengard, et al.
Pages: 71 - HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies(2009)
Authors: T Dieltjens, N Loots, K Vereecken, K Grupping, L Heyndrickx, E Bottieau, G Vanham, D. Davis, W Janssens
Pages: 1165-1169 - Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies(2009)
Authors: T Dieltjens, L Heyndrickx, B Willems, E Gray, L Van Nieuwenhove, K Grupping, G Vanham, W Janssens
Pages: 1-13